CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Psychemedics Corp  (PMD)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

PMD's Operating Income Growth by Quarter and Year

Psychemedics's Operating Income results by quarter and year




PMD Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 1.95 3.64 0.11
III Quarter September 2.12 2.23 4.10 0.55
II Quarter June 2.06 1.71 2.37 0.36
I Quarter March 1.91 2.27 - 0.45
FY   6.09 8.16 10.11 1.47



PMD Operating Income third quarter 2018 Y/Y Growth Comment
Psychemedics Corp reported decrease in Operating Income in the third quarter by -4.93% to $ 2.12 millions, from the same quarter in 2017.
The decrease in the third quarter Psychemedics Corp's Operating Income compares unfavorably to the Company's average Operating Income doubling of 189.77%.

Looking into third quarter results within Medical Laboratories industry 9 other companies have achieved higher Operating Income growth. While Psychemedics Corp' s Operating Income decline of -4.93% ranks overall at the positon no. 1646 in the third quarter.

Explain Operating Income growth


PMD Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - -46.43 % 3209.09 % -88.54 %
III Quarter September -4.93 % -45.61 % 645.45 % -55.65 %
II Quarter June 20.47 % -27.85 % 558.33 % -72.73 %
I Quarter March -15.86 % - - -61.54 %
FY   - -19.29 % 587.76 % -

Financial Statements
Psychemedics's third quarter 2018 Operating Income $ 0.00 millions PMD's Income Statement
Psychemedics's third quarter 2017 Operating Income $ 0.00 millions Quarterly PMD's Income Statement
New: More PMD's historic Operating Income Growth >>


PMD Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - -12.56 % -11.22 % -80 %
III Quarter September 2.91 % 30.41 % 73 % 52.78 %
II Quarter June 7.85 % -24.67 % - -20 %
I Quarter March -2.05 % -37.64 % - -53.13 %
FY (Year on Year)   - -19.29 % 587.76 % -




Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #97
Overall #1646

Operating Income Y/Y Growth Statistics
High Average Low
3100.34 % 189.77 % -88.13 %
(Dec 31 2016)   (Dec 31 2015)
Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #97
Overall #1646
Operating Income Y/Y Growth Statistics
High Average Low
3100.34 % 189.77 % -88.13 %
(Dec 31 2016)   (Dec 31 2015)

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Psychemedics's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
159.22 % 1.14 % -79.38 %
(Mar 31 2013)  


PMD's III. Quarter Q/Q Operating Income Comment
Psychemedics Corp achieved in the III. Quarter 2018 above company average sequential Operating Income growth of 2.91%, to $ 2.12 millions, from $2.06 millions in the second quarter.

Within Medical Laboratories industry Psychemedics Corp achieved highest sequential Operating Income growth. While Psychemedics's Operating Income growth quarter on quarter, overall rank is 141.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #8
Overall #141
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #8
Overall #141
Operating Income Q/Q Growth Statistics
High Average Low
159.22 % 1.14 % -79.38 %
(Mar 31 2013)  


PMD's III. Quarter Q/Q Operating Income Comment
Psychemedics Corp achieved in the III. Quarter 2018 above company average sequential Operating Income growth of 2.91%, to $ 2.12 millions, from $2.06 millions in the second quarter.

Within Medical Laboratories industry Psychemedics Corp achieved highest sequential Operating Income growth. While Psychemedics's Operating Income growth quarter on quarter, overall rank is 141.


Psychemedics's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Operating Income 12 Months Ending $ 8.03 $ 8.14 $ 7.80 $ 8.16 $ 9.85
Y / Y Operating Income Growth (TTM) -18.46 % -30.53 % -37.03 % -19.32 % 49.48 %
Year on Year Operating Income Growth Overall Ranking # 297 # 1585 # 254 # 0 # 1672
Seqeuential Operating Income Change (TTM) -1.38 % 4.44 % -4.44 % -17.16 % -15.97 %
Seq. Operating Income Growth (TTM) Overall Ranking # 275 # 898 # 2053 # 2116 # 1674




Cumulative Operating Income growth Comment
Psychemedics showed decline, but improvement compare to trailing twelve month Operating Income decrease in Jun 30 2018. If the fiscal year would end in Sep 30 2018, Psychemedics's annual Operating Income fall would be -18.46% year on year to $8 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 297, from total ranking in previous quarter at 1585.

Operating Income TTM Q/Q Growth Statistics
High Average Low
197.73 %
9.46 %
-36.45 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 19
Overall # 297

Operating Income TTM Y/Y Growth Statistics
High Average Low
1114.75 %
93.45 %
-74.34 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 18
S&P 500 # 275
Cumulative Operating Income growth Comment
Psychemedics showed decline, but improvement compare to trailing twelve month Operating Income decrease in Jun 30 2018. If the fiscal year would end in Sep 30 2018, Psychemedics's annual Operating Income drop would be -18.46% year on year to $8 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 297, from total ranking in previous quarter at 1585.

Operating Income TTM Q/Q Growth Statistics
High Average Low
197.73 %
9.46 %
-36.45 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 19
Overall # 297

Operating Income TTM Y/Y Growth Statistics
High Average Low
1114.75 %
93.45 %
-74.34 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 18
S&P 500 # 275




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PMD's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PMD's Competitors
Operating Income Growth for Psychemedics's Suppliers
Operating Income Growth for PMD's Customers

You may also want to know
PMD's Annual Growth Rates PMD's Profitability Ratios PMD's Asset Turnover Ratio PMD's Dividend Growth
PMD's Roe PMD's Valuation Ratios PMD's Financial Strength Ratios PMD's Dividend Payout Ratio
PMD's Roa PMD's Inventory Turnover Ratio PMD's Growth Rates PMD's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2018
Universal Health Services Inc -0.06 %$ -0.057 millions
Bio-techne Corp -1.03 %$ -1.030 millions
Msa Safety Incorporated -1.51 %$ -1.512 millions
Healthcare Services Group Inc -1.70 %$ -1.702 millions
Zynex Inc -3.92 %$ -3.918 millions
Amgen Inc. -4.76 %$ -4.756 millions
West Pharmaceutical Services Inc -4.85 %$ -4.851 millions
Psychemedics Corp -5.02 %$ -5.018 millions
Lifevantage Corp -5.29 %$ -5.293 millions
Utah Medical Products Inc -5.92 %$ -5.920 millions
Atrion Corp -6.29 %$ -6.290 millions
Prestige Consumer Healthcare Inc. -6.87 %$ -6.871 millions
Djo Finance Llc -8.67 %$ -8.673 millions
Lemaitre Vascular Inc -8.71 %$ -8.708 millions
Hologic Inc -9.41 %$ -9.415 millions
Magellan Health Inc -9.92 %$ -9.920 millions
Artemis Therapeutics, Inc. -10.57 %$ -10.573 millions
Hca Healthcare, Inc. -13.47 %$ -13.472 millions
Mednax, Inc. -13.66 %$ -13.660 millions
Conmed Corp -14.46 %$ -14.462 millions
Anika Therapeutics, Inc. -16.52 %$ -16.516 millions
Community Health Systems Inc -17.78 %$ -17.778 millions
Standard Diversified Inc. -18.14 %$ -18.140 millions
Meridian Bioscience Inc -19.27 %$ -19.269 millions
Henry Schein Inc -22.30 %$ -22.300 millions
Eagle Pharmaceuticals, Inc. -26.24 %$ -26.244 millions
Owens & Minor Inc -28.02 %$ -28.021 millions
Gilead Sciences Inc -31.19 %$ -31.191 millions
Mettler Toledo International Inc -31.52 %$ -31.518 millions
Lifepoint Health, Inc. -35.00 %$ -35.004 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LVYN's Profile

Stock Price

LVYN's Financials

Business Description

Fundamentals

Charts & Quotes

LVYN's News

Suppliers

LVYN's Competitors

Customers & Markets

Economic Indicators

LVYN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071